Year: 2019
Type: article
Abstract: Immune checkpoint inhibitors have efficacy in persons who have tumors with microsatellite instability (MSI). A recent study using a mouse model suggests that a specific type of mutation related to MSI drives the response.
Source: New England Journal of Medicine
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2965770429
